The Next Domino: Automation, AI, and touchless safety case processing


With the increasing volumes of adverse event reports and stagnant budgets, the time is now for a revolutionary change in drug and device safety case management. A robust management process is necessary for identifying and evaluating adverse events (AE) and reporting them properly to regulators.

Related Content
© 2024 MJH Life Sciences

All rights reserved.